Meningococcal Polysaccharide Vaccine
Product Description
Chongqing Zhifei Biological Products Co.
-
CN -
2015On CPHI since
-
5000+Employees
Company types
Categories
Specifications
Chongqing Zhifei Biological Products Co.
-
CN
-
2015On CPHI since
-
5000+Employees
Company types
More Products from Chongqing Zhifei Biological Products Co. (4)
-
Product Recombinant COVID-19 Vaccine(CHO Cell)
Zifivax is the first approved Recombinant COVID vaccine, there are more than 300million doses used worldwide. -
Product Recombinant Mycobacterium Tuberculosis Fusion Protein
C-TST is a new diagnose method to detect Mtb infectionfor,which uses antigen-specific (ESAT6 & CFP10) immune response, same with the principle of action used in IGRAs.(1）Suitable for Large Scale LTBI Screening；
(2）Non Cross-React with BCG Vaccine;
(3）WHO Guideline Recommended; q... -
Product semaglutide
we can supply the semaglutide API with a good price and good quality,we are also open for the cooperation model. -
Product Group A, C Meningococcal Polysaccharide-Conjugate Vaccine
MeningACon is the first approved product in China,more than 36 million doses has been used.
Chongqing Zhifei Biological Products Co. resources (1)
-
Brochure Zhifei Profile
Zhifei Profile
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance